Viewing Study NCT01000961

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:21 PM
Ignite Modification Date: 2026-03-01 @ 6:11 AM
Study NCT ID: NCT01000961
Status: COMPLETED
Last Update Posted: 2024-12-19
First Post: 2009-10-22
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Phase 3 Study of Cysteamine Bitartrate Delayed-release (RP103) Compared to Cystagon® in Patients With Cystinosis
Sponsor: Amgen
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cystinosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None cystinosis View
None cysteamine View
None inheritable disease View
None orphan disease View
None CTNS protein, human View
None metabolic disease View
None nephropathic cystinosis View